This helps prevent the activation of the T-cell which Typically would target and ruin cancer. The cancer cells can then multiply and spread. When Keytruda binds towards the PD-1 receptor it prevents cancer cells from linking to and inactivating T-cells, permitting T-cell re-activation, and boosting the immune system's response against cancer. This